Zoetis Inc. financial data

Symbol
ZTS on NYSE
Industry
Pharmaceutical Preparations
Location
10 Sylvan Way, Parsippany, NJ
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 282 % -19.2%
Quick Ratio 111 % -24.3%
Debt-to-equity 185 % -3.19%
Return On Equity 49.7 % +1.62%
Return On Assets 17.4 % +3.82%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 448M shares -2.2%
Common Stock, Shares, Outstanding 448M shares -2.16%
Entity Public Float 78.7B USD -0.85%
Common Stock, Value, Issued 5M USD 0%
Weighted Average Number of Shares Outstanding, Basic 454M shares -1.51%
Weighted Average Number of Shares Outstanding, Diluted 455M shares -1.61%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 9.26B USD +8.33%
Nonoperating Income (Expense) 19M USD -88.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3.13B USD +6.71%
Income Tax Expense (Benefit) 637M USD +6.88%
Net Income (Loss) Attributable to Parent 2.49B USD +6.06%
Earnings Per Share, Basic 5.47 USD/shares +7.68%
Earnings Per Share, Diluted 5.47 USD/shares +7.89%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.71B USD -2.28%
Accounts Receivable, after Allowance for Credit Loss, Current 1.32B USD +0.92%
Inventory, Net 2.31B USD -10.1%
Other Assets, Current 377M USD -13.1%
Assets, Current 5.99B USD -5.63%
Deferred Income Tax Assets, Net 540M USD +162%
Property, Plant and Equipment, Net 3.39B USD +5.84%
Operating Lease, Right-of-Use Asset 219M USD -4.78%
Intangible Assets, Net (Excluding Goodwill) 1.13B USD -15.8%
Goodwill 2.72B USD -1.27%
Other Assets, Noncurrent 250M USD +21.4%
Assets 14.2B USD -0.34%
Accounts Payable, Current 433M USD +5.35%
Employee-related Liabilities, Current 441M USD +15.4%
Accrued Liabilities, Current 746M USD +9.22%
Liabilities, Current 3.41B USD +80.6%
Accrued Income Taxes, Noncurrent 272M USD +0.37%
Deferred Income Tax Liabilities, Net 167M USD +14.4%
Operating Lease, Liability, Noncurrent 174M USD -7.45%
Other Liabilities, Noncurrent 222M USD -6.33%
Liabilities 9.47B USD +1.85%
Accumulated Other Comprehensive Income (Loss), Net of Tax -940M USD -12%
Retained Earnings (Accumulated Deficit) 12B USD +16.3%
Stockholders' Equity Attributable to Parent 4.77B USD -4.54%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 4.77B USD -4.43%
Liabilities and Equity 14.2B USD -0.34%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 595M USD +8.38%
Net Cash Provided by (Used in) Financing Activities -524M USD +70.9%
Net Cash Provided by (Used in) Investing Activities -131M USD +39.4%
Common Stock, Shares Authorized 6B shares 0%
Common Stock, Shares, Issued 502M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -66M USD +95.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.99B USD -2.65%
Interest Paid, Excluding Capitalized Interest, Operating Activities 68M USD -23.6%
Deferred Tax Assets, Valuation Allowance 123M USD -6.11%
Operating Lease, Liability 225M USD -4.66%
Payments to Acquire Property, Plant, and Equipment 140M USD -37.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2.39B USD +2.71%
Lessee, Operating Lease, Liability, to be Paid 258M USD -4.8%
Property, Plant and Equipment, Gross 6.03B USD +3.93%
Operating Lease, Liability, Current 51M USD +6.25%
Lessee, Operating Lease, Liability, to be Paid, Year Two 50M USD +4.17%
Lessee, Operating Lease, Liability, to be Paid, Year One 59M USD +3.51%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -43M USD -638%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 33M USD -5.71%
Lessee, Operating Lease, Liability, to be Paid, Year Three 39M USD +2.63%
Deferred Tax Assets, Operating Loss Carryforwards 139M USD +4.51%
Preferred Stock, Shares Authorized 1B shares 0%
Unrecognized Tax Benefits 213M USD +1.91%
Lessee, Operating Lease, Liability, to be Paid, Year Four 29M USD -3.33%
Operating Lease, Payments 15M USD +7.14%
Additional Paid in Capital 1.18B USD +4.33%
Amortization of Intangible Assets 170M USD -8.11%
Depreciation, Depletion and Amortization 497M USD +1.22%
Deferred Tax Assets, Net of Valuation Allowance 409M USD +115%
Share-based Payment Arrangement, Expense 18M USD +5.88%
Interest Expense 225M USD -5.86%